Cargando…

Dose adjustment of antidiabetic medications in chronic kidney disease

PURPOSE: The purpose of this study is to identify whether Internal Medicine house-staff (IMHS) have awareness and knowledge about the correct dosage of antidiabetic medications for patients with chronic kidney disease (CKD), as dosing errors result in adverse patient outcomes for those with diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Snyder, Matthew Salvatore, Fogel, Joshua, Pyatigorskaya, Svetlana, Rubinstein, Sofia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839266/ https://www.ncbi.nlm.nih.gov/pubmed/33520787 http://dx.doi.org/10.4103/ajm.ajm_110_20

Ejemplares similares

Awareness and knowledge among internal medicine house-staff for dose adjustment of commonly used medications in patients with CKD
por: Surana, Sikander, et al.
Publicado: (2017)

How to adjust drug doses in chronic kidney disease
por: Stefani, Maurizio, et al.
Publicado: (2019)

Drug-Dosing Adjustment in Dogs and Cats with Chronic Kidney Disease
por: De Santis, Francesca, et al.
Publicado: (2022)

Assessment of Medication Dosage Adjustment in Hospitalized Patients With Chronic Kidney Disease
por: Hassan, Zair, et al.
Publicado: (2021)

Evaluation of renal drug dosing adjustment in chronic kidney disease patients at two university hospitals in Lebanon
por: Saad, Rayane, et al.
Publicado: (2019)

Occupational risk and chronic kidney disease: a population-based study in the United States adult population
por: Rubinstein, Sofia, et al.
Publicado: (2013)

Role of antidiabetic agents in type 2 diabetes patients with chronic kidney disease
por: Lin, Wei-Ren, et al.
Publicado: (2023)

MELD-Na score, Acute Physiologic and Chronic Health Evaluation II score, and SOFA score and their association with mortality in critically ill COVID-19 patients with liver injury: A retrospective single-center study
por: Gomez-Paz, Sandra, et al.
Publicado: (2022)

Selection and Warning of Evidence-Based Antidiabetic Medications for Patients With Chronic Liver Disease
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Knowledge, attitude and perceptions of pharmacists regarding renal dose adjustment among chronic kidney disease patients in Pakistan
por: Zafar, Roheena, et al.
Publicado: (2023)

Weight-adjusted dosing of tinzaparin for thromboprophylaxis in obese medical patients
por: Pfrepper, Christian, et al.
Publicado: (2023)

Adjusted Anion Gap Is Associated with Glomerular Filtration Rate Decline in Chronic Kidney Disease
por: Togawa, Akashi, et al.
Publicado: (2013)

Glucose dysregulation and its association with COVID-19 mortality and hospital length of stay
por: Mirabella, Steven, et al.
Publicado: (2022)

Nonglycemic Outcomes of Antidiabetic Medications
por: Morse, Christopher, et al.
Publicado: (2019)

Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease – cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort
por: Busch, Martin, et al.
Publicado: (2016)

Antidiabetic Drugs in the Treatment of Alzheimer’s Disease
por: Michailidis, Michalis, et al.
Publicado: (2022)

Comparative effectiveness of incident oral antidiabetic drugs on kidney function
por: Hung, Adriana M, et al.
Publicado: (2012)

Pharmaceutical care program for patients with chronic kidney disease in the community pharmacy: Detection of nephrotoxic drugs and dose adjustment. Viability study
por: Escribá-Martí, Gema, et al.
Publicado: (2022)

Antidiabetic therapies and Alzheimer disease
por: Bendlin, Barbara B
Publicado: (2019)

Kidney function and clinical recommendations of drug dose adjustment in geriatric patients
por: Karsch-Völk, Marlies, et al.
Publicado: (2013)

Antidiabetic Properties of Plant Secondary Metabolites
por: Sukhikh, Stanislav, et al.
Publicado: (2023)

A clinical score to predict dose reductions of antidiabetes medications with intentional weight loss: A retrospective cohort study
por: Shantha, Ghanshyam Palamaner Subash, et al.
Publicado: (2016)

Efficacy and Cardiovascular Safety of Antidiabetic Medications
por: Pappachan, Joseph M.
Publicado: (2021)

Evaluation of Increased Adherence and Cost Savings of an Employer Value-Based Benefits Program Targeting Generic Antihyperlipidemic and Antidiabetic Medications
por: Clark, Bobby, et al.
Publicado: (2014)

Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches
por: Garcia-Romeu, Albert, et al.
Publicado: (2021)

Durability of initial antidiabetic monotherapy and subsequent treatment adjustment patterns among newly treated type 2 diabetes patients
por: Noh, Yoojin, et al.
Publicado: (2018)

Antidiabetic and Other Therapies Used in Subjects with Diabetes and Chronic Kidney Disease in a Hospital-Based Clinic Population in Greece
por: Migdalis, Ilias N., et al.
Publicado: (2021)

Dosing Frequency and Medication Adherence in Chronic Disease
por: Coleman, Craig I., et al.
Publicado: (2012)

Automating and estimating glomerular filtration rate for dosing medications and staging chronic kidney disease
por: Trinkley, Katy E, et al.
Publicado: (2014)

Hematologic Involvement as a Predictor of Mortality in COVID-19 Patients in a Safety Net Hospital
por: Gonzalez-Mosquera, Luis F., et al.
Publicado: (2022)

Kidney function estimators for drug dose adjustment of direct oral anticoagulants in older adults with atrial fibrillation
por: Villain, Cédric, et al.
Publicado: (2023)

Treatment patterns of antidiabetic and kidney protective therapies among patients with type 2 diabetes mellitus and chronic kidney disease in Colombia. The KDICO descriptive study
por: Machado-Duque, Manuel E, et al.
Publicado: (2023)

Utilization of oral antidiabetic medications in Taiwan following strategies to promote access to medicines for chronic diseases in community pharmacies
por: Hsu, Jason C, et al.
Publicado: (2015)

Novel Antidiabetic Medications in Polycystic Ovary Syndrome
por: Somagutta, Manoj Reddy, et al.
Publicado: (2022)

Effect of Chronic Kidney Disease on the Renal Secretion via Organic Anion Transporters 1/3: Implications for Physiologically‐Based Pharmacokinetic Modeling and Dose Adjustment
por: Tan, Shawn Pei Feng, et al.
Publicado: (2022)

Dose Adjustment of Subcutaneous IgG in Chronic Inflammatory Demyelinating Polyneuropathy
por: Alsolaihim, Alanood, et al.
Publicado: (2020)

Glomerular filtration rate as a kidney outcome of diabetic kidney disease: a focus on new antidiabetic drugs
por: Kim, Hyo Jin, et al.
Publicado: (2022)

Respiratory involvement parameters in hospitalized COVID-19 patients and their association with mortality and length of stay
por: Lam, Eric, et al.
Publicado: (2022)

Dose Adjustment of Concomitant Antiseizure Medications During Cenobamate Treatment: Expert Opinion Consensus Recommendations
por: Smith, Michael C., et al.
Publicado: (2022)

Antidiabetics and antihypertensive medications use in Morocco: A pharmacoepidemiological descriptive study
por: Rida, Elyamani, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_77naqm45gkfljlehktvgbhluok